A glance at what’s happening in the world of technology.
Gene therapy study offers hope to IRD sufferers
The visual function of mice suffering from inherited retinal disease (IRD) was restored in a US study hailed as a breakthrough.
Researchers from the University of California, Irvine (UCI), used new-generation CRISPR technology – known as base editing – to demonstrate a new therapeutic modality for a wide range of IRDs.
Co-author Krzysztof Palczewski, professor at the UCI’s Gavin Herbert Eye Institute, said: “We provide evidence of the clinical potential of base editors for the correction of mutations causing IRDs and for restoring visual function.
Sign in to continue
Not already a member of The College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
We are pleased to announce that each nation's health system has confirmed that they support a move to the ‘Green’ phase on Tuesday 10 May 2022. From then, the College’s COVID-19 Amber phase guidance will no longer apply in all UK nations.
